Altoida raises $6.3M Series A for AI Alzheimer's risk predictor - MassDevice
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases - Essentials
Altoida AG - Venture Kick
Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality | Venture Incubator
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson's Disease Diagnosis | Business Wire
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
Cognitive Health & Digital Biomarker Technologies | Altoida
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum
Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status | Fierce Biotech
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Cognitive Health & Digital Biomarker Technologies | Altoida
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Ο Έλληνας ερευνητής Ιωάννης Ταρνανάς κατέκτησε το κορυφαίο ευρωπαϊκό βραβείο καινοτομίας! Προβλέπει το Αλτσχάιμερ στα 6 χρόνια (Φωτό & Βίντεο) | eirinika.gr
Ioannis Tarnanas's email & phone | Altoida's Founder email
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
